In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COURAGE Trial: Bad News Again for Stents at ACC, Or Is It?

Executive Summary

For the second year in a row, results from a clinical trial announced at the annual American College of Cardiology (ACC) conference appeared to be bad news for coronary stents. The outcomes from the COURAGE trial, announced at this year's ACC meeting in New Orleans at the end of March, found that angioplasty with stenting did not reduce the risk of major adverse cardiovascular events when added to optimal medical therapy.
Advertisement

Related Content

Volcano Explodes in Therapy Guidance
Drug-Eluting Balloons: New Route to Revascularization
TCT Debates Cardiology's "Climate of Calamity"
ESC Highlights: DES Debate Continues, Hybrid-Imaging Hot Ticket
Profiles of COURAGE: Another Speed Bump for Stents or Flawed Trial?
At TCT, DES Use and Safety Concerns: Irrational Exuberance or Irrational Anxiety?
TCT Highlights: Late Stent Thrombosis Controversy Continues
Turning Around Medtronic Vascular
Renewed DES Safety Debate Creates Second Generation Mover Advantage
Conor: An Outsider Delivers Drug-Stents' Next Generation

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV002925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel